Latest Close
$51.52
News
CRSP
CRISPR Therapeutics AG News
This news view pulls recent coverage and headlines tied to CRSP.
1y Change
-$16.91 (-24.71%)
Market Cap
$4.98B
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
UBS Initiates CRISPR Therapeutics at Neutral With $52 Price Target
MT Newswires • Oct 15, 2026
Read articleIs CRISPR Therapeutics (CRSP) Undervalued As CASGEVY Hopes Face Market Doubts?
Simply Wall St. • Oct 14, 2026
Read articleCRISPR Therapeutics (CRSP) Stock Looks Rich On Upcoming CTX310 Trial Data
Simply Wall St. • Oct 14, 2026
Read articleMatchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire • Oct 14, 2026
Read articleCathie Wood Has Sold Nearly $18 Million of Meta in Days -- Here's What It Means
GuruFocus.com • Oct 13, 2026
Read articleCRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
Zacks • Oct 12, 2026
Read article